New research results explore the safety of short-term cultivated CAR T cells in cancer immunotherapy
by Susanne Stöcker, Paul-Ehrlich-Institut - Bundesinstitut für Impfstoffe und biomedizinische ArzneimittelTo make CAR T cells available to all patients, various strategies facilitating the manufacturi
Updated on: March 30,2024
0
New research results explore the safety of short-term cultivated CAR T cells in cancer immunotherapy
by Susanne Stöcker, Paul-Ehrlich-Institut - Bundesinstitut für Impfstoffe und biomedizinische ArzneimittelTo make CAR T cells available to all patients, various strategies facilitating the manufacturi
Updated on:March 30,2024
0
